- Latest available (Revised)
- Point in Time (01/07/2016)
- Original (As made)
Version Superseded: 26/11/2018
Point in time view as at 01/07/2016.
There are currently no known outstanding effects for the The National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013, PART 2.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
3. For the purposes of these Regulations, “essential services” means—
(a)the services described in this Part; and
(b)the activities described in this Part to be carried out in connection with those services.
4. An NHS pharmacist must, to the extent that paragraphs 5 to 9 require and in the manner described in those paragraphs, provide proper and sufficient drugs and appliances to persons presenting prescriptions for drugs or appliances ordered by health care professionals in pursuance of their functions in the health service, the Scottish health service or the Northern Ireland health service.
5.—(1) In this Part, “signed” includes signature with a prescriber's advanced electronic signature.
(2) Subject to the following provisions of this Part, where—
(a)any person presents to an NHS Pharmacist (P) a non-electronic prescription form which contains—
(i)an order for drugs, not being Scheduled drugs, or for appliances, not being restricted availability appliances, signed by a prescriber,
(ii)an order for a drug specified in Schedule 2 to the Prescription of Drugs Regulations M1 (drugs, medicines and other substances that may be ordered only in certain circumstances), signed by a prescriber and including the reference “SLS”, or
(iii)an order for a restricted availability appliance, signed by a prescriber and including the reference “SLS”; or
(b)subject to sub-paragraph (4), P receives from the Electronic Prescription Service an electronic prescription form which contains an order of a kind specified in paragraph (a)(i) to (iii) and—
(i)any person requests the provision of drugs or appliances in accordance with that prescription, or
(ii)P has previously arranged with the patient that P will dispense that prescription on receipt,
P must, with reasonable promptness, provide the drugs so ordered, and such of the appliances so ordered as P supplies in the normal course of business.
(3) Subject to the following provisions of this Part, where—
(a)any person presents to P a non-electronic repeatable prescription which contains—
(i)an order for drugs, not being Scheduled drugs or controlled drugs within the meaning of the Misuse of Drugs Act 1971 M2, other than a drug which is for the time being specified in Schedule 4 or 5 to the Misuse of Drugs Regulations 2001 M3 (which relate to controlled drugs excepted from certain prohibitions under the Regulations), signed by a prescriber,
(ii)an order for a drug specified in Schedule 2 to the Prescription of Drugs Regulations, not being a controlled drug within the meaning of the Misuse of Drugs Act 1971, other than a drug which is for the time being specified in Schedule 4 or 5 to the Misuse of Drugs Regulations 2001, signed by a prescriber and including the reference “SLS”,
(iii)an order for appliances, not being restricted availability appliances, signed by a prescriber, or
(iv)an order for a restricted availability appliance, signed by a prescriber, and including the reference “SLS”,
and also presents an associated batch issue; or
(b)P receives from the Electronic Prescription Service an electronic repeatable prescription which contains an order of a kind specified in paragraph (a)(i) to (iv) and—
(i)any person requests the provision of drugs or appliances in accordance with that repeatable prescription, or
(ii)P has previously arranged with the patient that P will dispense that repeatable prescription on receipt,
P must, with reasonable promptness, provide the drugs so ordered, and such of the appliances so ordered as P supplies in the normal course of business.
(4) P must not provide under an electronic prescription form a controlled drug within the meaning of the Misuse of Drugs Act 1971, other than a drug which is for the time being specified in [F1Schedules 2 to 5] to the Misuse of Drugs Regulations 2001.
(5) For the purposes of this paragraph, a non-electronic repeatable prescription for drugs or appliances shall be taken to be presented even if the person who wishes to obtain the drugs or appliances does not present that prescription, where—
(a)P has that prescription in P's possession; and
(b)that person presents, or P has in P's possession, an associated batch issue.
Textual Amendments
F1Words in Sch. 4 para. 5(4) substituted (1.7.2015) by The National Health Service (Amendments to Primary Care Terms of Service relating to the Electronic Prescription Service) Regulations 2015 (S.I. 2015/915), regs. 1, 4(2)
Marginal Citations
M1Schedule 2 has been amended by S.I. 2004/3215, 2009/2230, 2010/2389 and 2011/680 and 1043.
M21971 c.38; see section 2(1)(a) of that Act, which defines “controlled drug” for the purposes of that Act.
M3S.I. 2001/3998. Schedule 4 has been amended by S.I. 2003/1432, 2005/3372, 2007/2154, 2009/3136 and 2012/973, and Schedule 5 has been amended by S.I. 2005/2864.
6.—(1) This paragraph applies where, in a case of urgency, a prescriber requests an NHS pharmacist (P) to provide a drug or appliance.
(2) P may provide the drug or appliance requested before receiving a prescription form or repeatable prescription in respect of that drug or appliance, provided that—
(a)in the case of a request for a drug, the drug is neither—
(i)a Scheduled drug, nor
(ii)a controlled drug within the meaning of the Misuse of Drugs Act 1971, other than a drug which is for the time being specified in Schedule 4 or 5 to the Misuse of Drugs Regulations 2001 (which relate to controlled drugs excepted from certain prohibitions under the Regulations); and
(b)in the case of a request for a drug or an appliance, the prescriber undertakes to—
(i)give P a non-electronic prescription form or non-electronic repeatable prescription in respect of the drug or appliance within 72 hours of the request being made, or
(ii)transmit an electronic prescription to the Electronic Prescription Service within 72 hours of the request being made.
7.—(1) If a person specified in sub-paragraph (2) asks an NHS pharmacist (P) to do so—
(a)P must give an estimate of the time when the drugs or appliances will be ready; and
(b)if they are not ready by then, P must give a revised estimate of the time when they will be ready (until they are ready).
(2) A person specified in this sub-paragraph is a person—
(a)presenting a non-electronic prescription form or non-electronic repeatable prescription; or
(b)requesting the provision of drugs or appliances in accordance with an electronic prescription form or a repeatable prescription.
(3) Before providing any drugs or appliances in accordance with a prescription form or a repeatable prescription, P must ask any person who makes a declaration that the person named on the prescription form or the repeatable prescription does not have to pay the charges specified in regulation 3(1) [F2or (2)] of the Charges Regulations M4 (supply of drugs and appliances by chemists) by virtue of either—
(a)entitlement to exemption under [F3regulation 10(1)] of the Charges Regulations M5 (exemptions); or
(b)entitlement to remission of charges under regulation 5 of the Remission of Charges Regulations M6 (entitlement to full remission and payment),
to produce satisfactory evidence of such entitlement, unless the declaration is in respect of entitlement to exemption by virtue of sub-paragraph (a), (c), (d), (e), (f) or (g) of [F3regulation 10(1)] of the Charges Regulations or in respect of entitlement to remission by virtue of regulation 5(1)(e) or (2) of the Remission of Charges Regulations, and at the time of the declaration P already has such evidence available to P.
[F4(3A) In any case where no satisfactory evidence, as required by sub-paragraph (3), is produced to P, P must ensure before the drugs or appliances are provided that the person who was asked to produce that evidence is advised, in appropriate terms, that checks are routinely undertaken to ascertain entitlement to—
(a)exemption under the Charges Regulations; or
(b)remission of charges under the Remission of Charges Regulations,
where such entitlement has been claimed, as part of the arrangements for preventing or detecting fraud or error in relation to such claims.]
(4) If, in the case of a non-electronic prescription form or non-electronic repeatable prescription, no satisfactory evidence, as required by sub-paragraph (3), is produced to P, P shall endorse the form on which the declaration is made to that effect.
(5) In the case of an electronic prescription, P must transmit to the Electronic Prescription Service—
(a)in a case where exemption from or remission of charges is claimed for all or some of the items included in the prescription, a record of—
(i)the exemption category specified in [F3regulation 10(1)] of the Charges Regulations or the ground for remission under regulation 5 of the Remission of Charges Regulations which it is claimed applies to the case, and
(ii)whether or not satisfactory evidence was produced to P as required by sub-paragraph (3);
(b)in any case where a charge is due, confirmation that the relevant charge was paid; and
(c)in a case of a prescription for or including contraceptive substances, confirmation that no charge was payable in respect of those substances.
Textual Amendments
F2Words in Sch. 4 para. 7(3) substituted (1.4.2015) by The National Health Service (Charges for Drugs and Appliances) Regulations 2015 (S.I. 2015/570), reg. 1, Sch. 2 para. 5(4)(a)
F3Words in Sch. 4 para. 7 substituted (1.4.2015) by The National Health Service (Charges for Drugs and Appliances) Regulations 2015 (S.I. 2015/570), reg. 1, Sch. 2 para. 5(4)(b)
F4Sch. 4 para. 7(3A) inserted (E.) (1.7.2016) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) Regulations 2016 (S.I. 2016/296), regs. 1(1)(b), 4(2)
Marginal Citations
M4Regulation 3 has been amended by S.I. 2002/2352, 2003/1084, 2004/865, 2005/578, 2008/571, 2009/411, 2010/1727, 2011/518 and 2012/470.
M5Regulation 7 has been amended by S.I. 2000/3189, 2002/2352, 2004/696, 2005/578 and 2009/29.
M6Regulation 5 has been amended by S.I. 2004/663 and 936, 2006/562, 2008/1697 and 2009/411.
8.—(1) Where an NHS pharmacist (P) is presented with, or receives from the Electronic Prescription Service, a prescription form or a repeatable prescription, P must only provide the drugs or appliances so ordered—
(a)if the prescription form or repeatable prescription is duly signed and completed as described in paragraph 5(2) or (3); and
(b)in accordance with the order on the prescription form or repeatable prescription,
subject to any regulations in force under the Weights and Measures Act 1985 M7 and the following provisions of this Part.
(2) Drugs or appliances so ordered shall be provided either by or under the direct supervision of a registered pharmacist.
(3) Where the registered pharmacist referred to in sub-paragraph (2) is employed or engaged by P, the registered pharmacist must not be someone—
(a)who is disqualified from inclusion in a relevant list; or
(b)who is suspended from the GPhC register.
(4) If the order is for an appliance of a type requiring measuring and fitting (for example a truss), P must make all necessary arrangements for a registered pharmacist—
(a)to measure the person named on the prescription form or repeatable prescription for the appliance; and
(b)to fit the appliance.
(5) If the order is for a drug or appliance included in the Drug Tariff, the British National Formulary (including any Appendix published as part of that Formulary), the Dental Practitioner's Formulary, the European Pharmacopoeia or the British Pharmaceutical Codex, the drug or appliance provided must comply with any relevant standard or formula specified therein.
(6) If the order—
(a)is an order for a drug; but
(b)is not an order for a controlled drug within the meaning of the Misuse of Drugs Act 1971, other than a drug which is for the time being specified in Schedule 4 or 5 to the Misuse of Drugs Regulations 2001 M8 (which relate to controlled drugs excepted from certain prohibitions under the Regulations),
and does not prescribe its quantity, strength or dosage, P (in this context, a registered pharmacist) may provide the drug in such strength and dosage as in the exercise of their professional skill, knowledge and care P considers to be appropriate and, subject to sub-paragraph (7), in such quantity as P considers to be appropriate for a course of treatment for a period not exceeding 5 days.
(7) Where an order to which sub-paragraph (6) applies is for—
(a)an oral contraceptive substance;
(b)a drug, which is available for supply as part of pharmaceutical services only together with one or more other drugs; or
(c)an antibiotic in a liquid form for oral administration in respect of which pharmaceutical considerations require its provision in an unopened package,
which is not available for provision as part of pharmaceutical services except in such packages that the minimum size available contains a quantity appropriate to a course of treatment for a period of more than 5 days, P may provide the minimum size available package.
(8) Where any drug to which this paragraph applies (that is, a drug that is not one to which the Misuse of Drugs Act 1971 applies, unless it is a drug for the time being specified in Schedule 5 to the Misuse of Drugs Regulations 2001), ordered by a prescriber on a prescription form or repeatable prescription, is available for provision by P in a pack in a quantity which is different to the quantity which has been so ordered, and that drug is—
(a)sterile;
(b)effervescent or hygroscopic;
(c)a liquid preparation for addition to bath water;
(d)a coal tar preparation;
(e)a viscous preparation; or
(f)packed at the time of its manufacture in a special container,
P must provide the drug in the pack whose quantity is nearest to the quantity which has been so ordered.
(9) In this paragraph, “special container” means any container with an integral means of application or from which it is not practicable to dispense an exact quantity.
(10) Subject to sub-paragraph (11), where a drug is ordered by a prescriber on a prescription form or a repeatable prescription in a quantity that is, or is a multiple of a quantity that is, readily available in a pack size manufactured for a marketing authorisation holder for the drug, P must provide the drug in an original pack (or in original packs) of that size which has been assembled by a manufacturer of the drug for such a marketing authorisation holder, unless—
(a)it is not possible for P to obtain such a pack (or packs) with reasonable promptness in the normal course of business; or
(b)it is not practicable for P to provide such a pack (or packs) in response to the order (for example, because of patient needs or the method of administration of the drug).
(11) In the case of oral liquid methadone, P (in practice, a registered pharmacist) must decide whether it would be most appropriate to provide—
(a)each dose in a separate container;
(b)an original pack (or original packs); or
(c)the oral liquid methadone in some other way,
and P must then provide it in packaging that accords with that decision.
(12) P must only provide a Scheduled drug in response to an order by name, formula or other description on a prescription form or repeatable prescription if—
(a)it is ordered as specified in sub-paragraph (13); or
(b)in the case of a drug specified in Schedule 2 to the Prescription of Drugs Regulations M9 (drugs, medicines and other substances that may be ordered only in certain circumstances), it is ordered in the circumstances prescribed in that Schedule.
(13) A Scheduled drug that is a drug with an appropriate non-proprietary name may be provided in response to an order on a prescription form or repeatable prescription for a drug (“the prescribed drug”) that is not a Scheduled drug but which has the same non-proprietary name as the Scheduled drug if—
(a)the prescribed drug is ordered by that non-proprietary name or by its formula;
(b)the prescribed drug has the same specification as the Scheduled drug (so the Scheduled drug may be dispensed generically); and
(c)the Scheduled drug is not in a pack which consists of a drug in more than one strength, and providing it would involve the supply of part only of the pack.
(14) If a Scheduled drug is a combination of more than one drug, it can only be ordered as specified in sub-paragraph (13) if the combination has an appropriate non-proprietary name, whether or not the drugs in the combination each have such names.
(15) P must provide any drug which P is required to provide under paragraph 5 in a suitable container.
Marginal Citations
M8S.I. 2001/3998. Schedule 4 has been amended by S.I. 2003/1432, 2005/3372, 2007/2154, 2009/3136 and 2012/973, and Schedule 5 has been amended by S.I. 2005/2864.
M9Schedule 2 has been amended by S.I. 2004/3215, 2009/2230, 2010/2389 and 2011/680 and 1043.
9.—(1) An NHS pharmacist (P) may refuse to provide the drugs or appliances ordered on a prescription form or repeatable prescription where—
(a)P reasonably believes that it is not a genuine order for the person named on the prescription form or the repeatable prescription (for example because P reasonably believes it has been stolen or forged);
(b)it appears to P that there is an error on the prescription form or on the repeatable prescription or, in the case of a non-electronic repeatable prescription, its associated batch issue (including a clinical error made by the prescriber) or that, in the circumstances, providing the drugs or appliances would be contrary to P's (in practice, a registered pharmacist's) clinical judgement;
(c)P or other persons on the premises are subjected to or threatened with violence by the person presenting the prescription form or repeatable prescription or requesting the provision of drugs or appliances in accordance with an electronic prescription form or a repeatable prescription, or by any person accompanying that person;
(d)the person presenting the prescription form or repeatable prescription or requesting the provision of drugs or appliances in accordance with an electronic prescription form or a repeatable prescription, or any other person accompanying that person, commits or threatens to commit a criminal offence; or
(e)the prescription form or repeatable prescription is incomplete because it does not include the information relating to the identification of the prescriber that the NHSCB (or a person exercising its functions) requires in order to perform its functions relating to—
(i)the remuneration of persons providing pharmaceutical services, and
(ii)any apportionment of, or any arrangements for recharging in respect of, that remuneration,
unless P (or the person who employs or engages P) is to receive no pharmaceutical remuneration of any kind in respect of the drug or appliance.
(2) P must refuse to provide a drug ordered on a prescription form or repeatable prescription where the order is for a prescription only medicine which the prescriber was not entitled to prescribe.
(3) P must refuse to provide drugs or appliances ordered on a repeatable prescription where—
(a)P has no record of that prescription (other than on the first occasion on which the prescription is presented);
(b)P does not, in the case of a non-electronic repeatable prescription, have any associated batch issue and it is not presented to P;
(c)it is not signed by a prescriber;
(d)to do so would not be in accordance with any intervals specified in the prescription;
(e)it would be the first time a drug or appliance had been provided pursuant to the prescription and the prescription was signed (whether electronically or otherwise) more than 6 months previously;
(f)the repeatable prescription was signed (whether electronically or otherwise) more than one year previously;
(g)the expiry date on the repeatable prescription has passed; or
(h)P has been informed by the prescriber that the prescription is no longer required.
(4) Where a patient requests the supply of drugs or appliances ordered on a repeatable prescription (other than on the first occasion that the patient makes such a request), P must only provide the drugs or appliances ordered if P is satisfied—
(a)that the patient to whom the prescription relates—
(i)is taking or using, and is likely to continue to take or use, the drug or appliance appropriately, and
(ii)is not suffering from any side effects of the treatment which indicates the need or desirability of reviewing the patient's treatment;
(b)that the medication regimen of, or manner of utilisation of the appliance by, the patient to whom the prescription relates has not altered in a way which indicates the need or desirability of reviewing the patient's treatment; and
(c)there have been no changes to the health of the patient to whom the prescription relates which indicate the need or desirability of reviewing the patient's treatment.
10.—(1) In connection with the services provided under paragraph 4, an NHS pharmacist (P) must—
(a)ensure that appropriate advice is given to patients about any drugs or appliances provided to them—
(i)to enable them to utilise the drugs or appliances appropriately, and
(ii)to meet the patient's reasonable needs for general information about the drugs or appliances;
(b)provide appropriate advice to patients to whom they provide drugs or appliances on—
(i)the safe keeping of the drugs or appliances, and
(ii)returning unwanted drugs or appliances to the pharmacy premises for safe destruction;
(c)when providing drugs to patients in accordance with a repeatable prescription, provide appropriate advice in particular on the importance of only requesting those items which they actually need;
(d)when providing appliances to patients in accordance with a prescription form or repeatable prescription—
(i)provide appropriate advice in particular on the importance of only requesting those items which they actually need, and
(ii)for those purposes, have regard to the details contained in the records maintained under paragraph (f) in respect of the provision of appliances and prescribing pattern relating to the patient in question;
[F5(da)ensure that appropriate advice about the benefits of repeat dispensing is given to any patient who—
(i)has a long term, stable medical condition (that is, a medical condition that is unlikely to change in the short to medium term), and
(ii)requires regular medicine in respect of that medical condition,
including, where appropriate, advice that encourages the patient to discuss repeat dispensing of that medicine with a prescriber at the provider of primary medical services whose patient list the patient is on;]
(e)provide a patient with a written note of any drug or appliance which is owed, and inform the patient when it is expected that the drug or appliance will become available;
(f)keep and maintain records—
(i)of drugs and appliances provided, in order to facilitate the continued care of the patient;
(ii)in appropriate cases, of advice given and any interventions or referrals made (including clinically significant interventions in cases involving repeatable prescriptions), and
(iii)of notes provided under sub-paragraph (e);
(g)undertake appropriate training in respect of repeat dispensing, having regard to any recommendations in respect of such training set out in the Drug Tariff;
(h)if P takes possession of a non-electronic repeatable prescription or an associated batch issue, securely store that repeatable prescription or associated batch issue;
(i)if P provides a drug or appliance under an electronic prescription, provide the patient, if the patient so requests, with a written record of the drugs or appliances ordered on that prescription and, in the case of an electronic repeatable prescription, of the number of occasions on which it can be dispensed;
(j)maintain records of repeatable prescriptions in such a form as to provide a clear audit trail of supplies under the repeatable prescription (including dates and quantities supplied);
(k)destroy any surplus batch issues relating to drugs or appliances—
(i)which are not required, or
(ii)where a patient is refused the drugs or appliances pursuant to paragraph 9;
(l)ensure that where a person is refused drugs or appliances pursuant to paragraphs 9(1)(b), (2), (3) or (4), the patient is referred back to the prescriber for further advice;
(m)where a patient is provided with drugs or appliances under a repeatable prescription, notify the prescriber of any clinically significant issues arising in connection with the prescription and keep a record of that notification;
(n)notify the prescriber of any refusal to provide drugs or appliances pursuant to paragraph 9(4);
(o)when providing appliances, provide a patient with a written note of P's name, address and telephone number; and
(p)when providing specified appliances, comply with the additional requirements set out in paragraph 12.
(2) Where, on presentation of a prescription form or repeatable prescription in connection with the dispensing services under paragraph 4, P is unable to provide an appliance, or stoma appliance customisation is required and P is unable to provide that, P shall—
(a)if the patient consents, refer the prescription form or repeatable prescription to another NHS pharmacist or to an NHS appliance contractor; and
(b)if the patient does not consent to a referral, provide the patient with contact details of at least 2 people who are NHS pharmacists or NHS appliance contractors who are able to provide the appliance or stoma appliance customisation (as the case may be), if these details are known to P.
Textual Amendments
F5Sch. 4 para. 10(1)(da) inserted (1.3.2015) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment and Transitional Provision) Regulations 2015 (S.I. 2015/58), regs. 1(1), 8(2) (with reg. 10)
11.—(1) An NHS pharmacist (P) must, if requested to do so by any person—
(a)explain to that person the Electronic Prescription Service, whether or not it is a service which is available through P's pharmacy premises; and
(b)where the Electronic Prescription Service is not available through P's pharmacy premises, provide that person with contact details of at least 2 NHS pharmacists in the area at whose premises the service is available, if these details are known to P.
(2) Where the Electronic Prescription Service is available through P's pharmacy premises, P must, if requested to do so by any person, enter in that person's PDS patient details—
(a)where the person does not have a nominated dispensing contractor, the dispensing contractor chosen by that person; or
(b)where the person does have a nominated dispensing contractor—
(i)a replacement dispensing contractor, or
(ii)a further dispensing contractor,
chosen by that person.
(3) Sub-paragraph (2)(b)(ii) does not apply if the number of nominated dispensing contractors for that person would thereby exceed the maximum number permitted by the Electronic Prescription Service.
(4) Regulation 116(a) to (c) applies to a request under this paragraph as it applies to an application to an NHS chemist for pharmaceutical services.
(5) If P is a nominated dispensing contractor for a person (X) but the nomination was made before P became the person listed in a pharmaceutical list in relation to the pharmacy premises nominated in X's PDS patient details, P must within 6 months of P becoming the person so listed—
(a)explain to X that the ownership of the pharmacy premises has changed; and
(b)ask X whether X wishes to maintain the nomination in respect of those pharmacy premises.
12.—(1) This paragraph sets out the additional requirements referred to in paragraph 10(1)(p) relating to the provision of specified appliances.
(2) An NHS pharmacist (P) who dispenses specified appliances in the normal course of business must provide a home delivery service in respect of those appliances and, as part of that service—
(a)P must offer to deliver the specified appliance to the patient's home;
(b)if the patient accepts that offer, the delivery must be made with reasonable promptness and at such time as is agreed with the patient;
(c)the specified appliance must be delivered in a package which displays no writing or other markings which could indicate its content; and
(d)the manner of delivery of the package and any supplementary items required by sub-paragraph (3) must not convey the type of appliance being delivered.
(3) In any case where a specified appliance is provided (whether by home delivery or otherwise), P must provide a reasonable supply of appropriate supplementary items (such as disposable wipes and disposal bags) and—
(a)must ensure that the patient may, if the patient wishes, consult a person to obtain expert clinical advice regarding the appliance; or
(b)if P believes it is appropriate to do so, must—
(i)refer the patient to a prescriber, or
(ii)offer the patient an appliance use review service.
(4) If P is unable to provide an appliance use review service in accordance with sub-paragraph (3)(b)(ii), P must give the patient the contact details of at least 2 people who are NHS pharmacists or NHS appliance contractors who are able to arrange for the service to be provided, if these details are known to P.
(5) Where P provides a telephone care line in respect of the dispensing of any specified appliance, P must ensure that during out of hours periods—
(a)advice is made available to patients through that telephone care line; or
(b)[F6telephone or website contact details for providers of NHS services that may be consulted for advice regarding specified appliances during those periods], are made available to patients through that telephone care line.
(6) For the purposes of this paragraph—
“expert clinical advice”, in relation to a specified appliance, means advice which is given by a person who is suitably trained and who has relevant experience in respect of the appliance;
“out of hours periods”, in relation to pharmacy premises, means the periods outside the core opening hours and any supplementary opening hours of the premises.
Textual Amendments
F6Words in Sch. 4 para. 12(5)(b) substituted (1.4.2014) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment and Transitional Provision) Regulations 2014 (S.I. 2014/417), regs. 1, 18
13. An NHS pharmacist must, to the extent paragraph 14 requires and in the manner described in that paragraph, accept and dispose of unwanted drugs presented to the NHS pharmacist for disposal.
14.—(1) Subject to paragraph (2), where a person presents to an NHS pharmacist (P) any drugs provided for a patient in, and which have been kept in—
(a)a private household; or
(b)a children's home; or
(c)a residential care home, that is to say an establishment which exists wholly or mainly for the provision of residential accommodation, together with board and personal care, for persons in need of personal care because of—
(i)old age,
(ii)mental or physical disability,
(iii)past or present dependence on alcohol or drugs,
(iv)any past illnesses, or
(v)past or present mental disorder,
P must accept the drugs and dispose of them in accordance with sub-paragraph (3).
(2) P is not required to accept any drugs for disposal unless the NHSCB has made arrangements for the collection and disposal of drugs of that description.
(3) On receipt of the drugs, P must—
(a)where required to do so by the NHSCB or by a waste disposal contractor retained by the NHSCB, separate solid drugs or ampoules, liquids and aerosols from each other;
(b)store the drugs in containers provided by the NHSCB, or by a waste disposal contractor retained by the NHSCB, for the purpose of storing drugs of that description; and
(c)comply with any other statutory requirements in respect of storing or the disposal of drugs of that description (meeting those requirements are therefore an essential service for the purposes of these Regulations),
and shall co-operate with any suitable arrangements that the NHSCB has in place for regular collection of the drugs from P's pharmacy premises by or on behalf of the NHSCB.
15. In connection with the services provided under paragraph 13, an NHS pharmacist (P) must—
(a)ensure that P (including P's staff) is aware of the risks associated with the handling of waste drugs and the correct procedures to be used to minimise those risks; and
(b)ensure that P (including P's staff) has readily available, and close to any place where waste drugs are stored, appropriate protective equipment, including gloves, overalls and materials to deal with spillages.
16. An NHS pharmacist must, to the extent paragraphs 17 and 18 require, and in the manner set out in those paragraphs, promote public health messages to members of the public.
17.—(1) Where a person using a pharmacy—
(a)presents a non-electronic prescription form or non-electronic repeatable prescription to an NHS pharmacist (P) or requests the provision of drugs or appliances in accordance with an electronic prescription; and
(b)it appears to P that the person—
(i)has diabetes,
(ii)is at risk of coronary heart disease, especially those with high blood pressure, or
(iii)smokes or is overweight,
P must, as appropriate, provide advice to that person with the aim of increasing that person's knowledge and understanding of the health issues which are relevant to that person's personal circumstances.
(2) Advice given under sub-paragraph (1) may be backed up, as appropriate—
(a)by the provision of written material (for example leaflets); and
(b)by referring the person to other sources of information or advice.
(3) P must, in appropriate cases, keep and maintain a record of advice given pursuant to this paragraph, and that record must be in a form that facilitates—
(a)auditing of the provision of pharmaceutical services by P; and
(b)follow-up care for the person who has been given the advice.
18. An NHS pharmacist (P) must, at the request of the NHSCB, ensure that—
(a)P (including P's staff) participates, in the manner reasonably requested by the NHSCB, in up to 6 campaigns in each calendar year to promote public health messages to users of P's pharmacy;
(b)where requested to do so by the NHSCB, P records the number of people to whom P (including P's staff) has provided information as part of one of those campaigns.
19. An NHS pharmacist must, to the extent paragraph 20 requires and in the manner set out in that paragraph, provide information to users of the NHS pharmacist's pharmacy about other health and social care providers and support organisations.
20.—(1) Where it appears to an NHS pharmacist (P), having regard to the need to minimise inappropriate use of health and social care services and of support services, that a person using P's pharmacy—
(a)requires advice, treatment or support that P cannot provide; but
(b)another provider, of which P is aware, of health or social care services or of support services is likely to be able to provide that advice, treatment or support,
P must provide contact details of that provider to that person and must, in appropriate cases, refer that person to that provider.
(2) Where, on presentation of a prescription form or repeatable prescription, P is unable to provide an appliance or stoma appliance customisation because the provision of the appliance or customisation is not within P's normal course of business, P must—
(a)if the patient consents, refer the prescription form or repeatable prescription to another NHS pharmacist or to an NHS appliance contractor; and
(b)if the patient does not consent to a referral, provide the patient with contact details of at least 2 people who are NHS pharmacists or NHS appliance contractors who are able to provide the appliance or stoma appliance customisation (as the case may be), if these details are known to P.
(3) Where appropriate, a referral under this paragraph may be made by means of a written referral note.
(4) P must, in appropriate cases, keep and maintain a record of any information given or referral made under this paragraph and that record must be in a form that facilitates—
(a)auditing of the provision of pharmaceutical services by P; and
(b)follow-up care for the person who has been given the information or in respect of whom the referral has been made.
21. An NHS pharmacist must, to the extent paragraph 22 requires and in the manner set out in that paragraph, provide advice and support to people caring for themselves or their families.
22.—(1) Where it appears to an NHS pharmacist (P), having regard to the need to minimise the inappropriate use of health and social care services, that a person (X) using P's pharmacy would benefit from advice from P to help X manage a medical condition (including, in the case of a carer, to help X in assisting in the management of another person's medical condition), P must provide advice to X as regards managing the medical condition, including, as appropriate, advice—
(a)on treatment options, including advice on the selection and use of appropriate drugs which are not prescription only medicines; and
(b)on changes to the patient's lifestyle.
(2) P must, in appropriate cases, keep and maintain a record of any advice given under sub-paragraph (1), and of any drugs supplied when the advice was given, and that record shall be in a form that facilitates—
(a)auditing of the provision of pharmaceutical services by P; and
(b)follow-up care for the person to whom or in respect of whom the advice has been given.
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Whole Instrument you have selected contains over 200 provisions and might take some time to download.
Would you like to continue?
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: